B-l cells: Orthodox or conformist?

Current Opinion in Immunology

Volumn 12, Issue 2, 2000, Pages 191-194

  Su, I Hsin ^a   Tarakhovsky, Alexander ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; AUTOANTIBODY; AUTOANTIGEN; B LYMPHOCYTE ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR; PHORBOL ESTER; THY 1 ANTIGEN;

B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL SELECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; SHORT SURVEY; SIGNAL TRANSDUCTION; ANIMAL; AUTOIMMUNITY; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINEAGE; CYTOLOGY; DRUG EFFECT; GENE REARRANGEMENT; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; REVIEW; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD5; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANTIGENS, THY-1; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CELL LINEAGE; CLONAL DELETION; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; PHORBOL ESTERS; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 0033622176     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00071-0     Document Type: Review

References (28)

1. Kantor A.B., Herzenberg L.A. Origin of murine B cell lineages. Annu Rev Immunol. 11:1993;501-538.
2. Hardy R.R., Carmack C.E., Li Y.S., Hayakawa K. Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol Rev. 137:1994;91-118.
3. Cornall R.J., Goodnow C.C., Cyster J.G. The regulation of self-reactive B cells. Curr Opin Immunol. 7:1995;804-811.
4. Hayakawa K., Hardy R.R., Honda M., Herzenberg L.A., Steinberg A.D. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA. 81:1984;2494-2498.
5. Hardy R.R., Hayakawa K. CD5 B cells, a fetal B cell lineage. Adv Immunol. 55:1994;297-339.
6. Cong Y.Z., Rabin E., Wortis H.H. Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol. 3:1991;467-476.
7. Bandyopadhyay R.S., Teutsch M.R., Wortis H.H. Activation of B-cells by sIgM cross-linking induces accumulation of CD5 mRNA. Curr Top Microbiol Immunol. 194:1995;219-228.
8. Clarke S.H., Arnold L.W. B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J Exp Med. 187:1998;1325-1334. The lack of functional Btk leads to the generation of B-2 cells expressing the normally B-1-specific autoreactive antiphospatidylcholine immunoglobulin. Since Btk is involved in BCR-mediated signalling, this observation supports the idea of BCR-induced differentiation of B-1 cells.
9. Haughton G., Arnold L.W., Whitmore A.C., Clarke S.H. B-1 cells are made, not born. Immunol Today. 14:1993;84-87.
10. Murakami M., Tsubata T., Okamoto M., Shimizu A., Kumagai S., Imura H., Honjo T. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature. 357:1992;77-80.
11. Arnold L.W., Pennell C.A., McCray S.K., Clarke S.H. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med. 179:1994;1585-1595.
12. Tatu C., Ye J., Arnold L.W., Clarke S.H. Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J Exp Med. 190:1999;903-914. This is an extension of the study described in [11]. The authors propose a mechanism responsible for the selection of B-1 cells by the autoantigen at multiple checkpoints during B cell development.
13. Hayakawa K., Asano M., Shinton S.A., Gui M., Allman D., Stewart C.L., Silver J., Hardy R.R. Positive selection of natural autoreactive B cells. Science. 285:1999;113-116. This is an elegant study which demonstrates the positive selection of B-1 cells by autoantigen. Expression of the autoantigen Thy-1 does not interfere with the generation and accumulation of B-1 cells expressing anti-Thy-1 antibody. However, the lack of this antigen (in Thy-1 deficient mice) abrogates the development and selection of anti-Thy-1-expressing B-1 but not B-2 cells.
14. HB1-8 possess the B-1 phenotype. The data suggest that a developing B cell might be equally able to become B-1 or B-2 cells depending on the specificity and the expression levels of surface immunoglobulin.
15. Morris D.L., Rothstein T.L. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes. J Exp Med. 177:1993;857-861.
16. Qin X.F., Schwers S., Yu W., Papavasiliou F., Suh H., Nussenzweig A., Rajewsky K., Nussenzweig M.C. Secondary V(D)J recombination in B-1 cells. Nature. 397:1999;355-359. This paper describes the possible molecular mechanism of the generation of the B-1-specific antibody repertoire. The authors suggest that the expression of the recombinase-activating genes 1 and 2 (RAG 1 and 2) in B-1 cells may support an ongoing secondary V(D)J recombination of immunoglobulin genes thus contributing to the generation of autoreactive antibodies.
17. Sen G., Bikah G., Venkataraman C., Bondada S. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur J Immunol. 29:1999;3319-3328. The authors demonstrate that SHP-1 is constitutively associated with the B cell antigen-receptor (BCR) in both B-1 and B-2 cells. However upon activation of the BCR by cross-linking, the amount of SHP-1 associated with the receptor decreases in splenic B-2 cells but remains constant in peritoneal B-1 cells. The persistent association between the BCR and SHP-1 in B-1 cells upon activation of the receptor seems to be mediated by CD5.
18. Cohen D.P., Rothstein T.L. Elevated levels of protein kinase C activity and alpha-isoenzyme expression in murine peritoneal B cells. J Immunol. 146:1991;2921-2927.
19. Karras J.G., Wang Z., Huo L., Howard R.G., Frank D.A., Rothstein T.L. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J Exp Med. 185:1997;1035-1042.
20. Tanguay D.A., Colarusso T.P., Pavlovic S., Irigoyen M., Howard R.G., Bartek J., Chiles T.C., Rothstein T.L. Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes. J Exp Med. 189:1999;1685-1690. The authors show that the rapid cell cycle progression observed in B-1 cells upon phorbol myristate acetate (PMA) stimulation is accompanied by unusually early expression of cyclin D2. Consistent with the observations in [21], the authors speculate that STAT proteins may play a role in regulating cyclin D2 expression.
21. Leitges M., Schmedt C., Guinamard R., Davoust J., Schaal S., Stabel S., Tarakhovsky A. Immunodeficiency in protein kinase Cbeta-deficient mice. Science. 273:1996;788-791.
22. Kearney J.F. Early B-cell repertoires. Curr Top Microbiol Immunol. 182:1992;81-84.
23. Pospisil R., Mage R.G. CD5 and other superantigens as 'ticklers' of the B-cell receptor. Immunol Today. 19:1998;106-108.
24. Suzuki H., Terauchi Y., Fujiwara M., Aizawa S., Yazaki Y., Kadowaki T., Koyasu S. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science. 283:1999;390-392.
25. Fruman D.A., Snapper S.B., Yballe C.M., Davidson L., Yu J.Y., Alt F.W., Cantley L.C. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science. 283:1999;393-397. Mice deficient for the p85α subunit of phosphoinositide 3-kinase (PI3K) were used in the studies described in references [23,24]. Both mouse strains have reduced numbers of B-1 cells and develop an Xid-like immunodeficiency. The authors conclude that p85α may be involved in the Btk pathway of antigen-receptor-mediated signal transduction. These results are consistent with earlier findings that demonstrate the functional interaction between Btk and PI3K.
26. Rickert R.C., Rajewsky K., Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature. 376:1995;352-355.
27. Zhang R., Alt F.W., Davidson L., Orkin S.H., Swat W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature. 374:1995;470-473.
28. Tarakhovsky A., Turner M., Schaal S., Mee P.J., Duddy L.P., Rajewsky K., Tybulewicz V.L. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature. 374:1995;467-470.